Celecoxib accelerates functional recovery after sciatic nerve crush in the rat

Area of Science:

• Neuroscience
• Pharmacology
• Regenerative Medicine

Background:

• Peripheral nerve injury triggers an inflammatory response crucial for degeneration and regeneration.
• Cyclooxygenase-2 (COX-2) is upregulated at injury sites, suggesting a role in inflammation regulation.
• Investigating COX-2 inhibitors may offer therapeutic strategies for nerve repair.

Purpose of the Study:

• To evaluate the efficacy of celecoxib, a COX-2 inhibitor, in promoting functional recovery after sciatic nerve crush injury in a rat model.
• To assess the impact of celecoxib on nerve regeneration and functional outcomes.

Main Methods:

• Sciatic nerve crush injury was induced in Wistar rats.
• Experimental group received daily celecoxib injections, while the control group received saline.
• Functional recovery was measured using the sciatic functional index (SFI) and onset of motor/walking function.

Main Results:

• Celecoxib treatment significantly improved the sciatic functional index (SFI) compared to the control group.
• A notably better SFI score was observed on day 7 in the celecoxib-treated group.
• The study registered the day of motor and walking onset for functional assessment.

Conclusions:

• Celecoxib demonstrates significant beneficial effects on functional recovery following peripheral nerve injury.
• The anti-inflammatory drug celecoxib warrants consideration for treating peripheral nerve injuries.
• Further research is necessary to elucidate the precise neuroprotective mechanisms of celecoxib.